MENU
KPTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Karyopharm Therapeutics (KPTI) Ownership - Who owns Karyopharm Therapeutics?

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
228
Web
https://www.karyopharm.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
218.92M
P/E Ratio
N/A
Total Cash
90.85M
Projected Growth
N/A
Total Debt
230.87M
Revenue
151.12M
Risk (Beta)
2.04
Dividend Yield
N/A
Total Cash/Share
4.01
Total Debt/Equity
N/A
Revenue/Share
10.08 USD as % of share price
View a ticker or compare two or three
KPTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
228
Web
https://www.karyopharm.com